세계의 분자량 마커 시장 : 유형, 딜리버리 방법, 포장, 기술, 용도, 지역별 분석 및 예측(-2030년)

According to Stratistics MRC, the Global Molecular Weight Marker Market is accounted for $0.98 billion in 2024 and is expected to reach $2.42 billion by 2030 growing at a CAGR of 15.2% during the forecast period. A molecular weight marker, also known as a protein or DNA ladder, is a set of standards containing molecules of known sizes used in gel electrophoresis. It serves as a reference to estimate the molecular weight of unknown proteins, nucleic acids, or other biomolecules by comparing their migration through a gel matrix. The marker consists of bands corresponding to specific molecular weights, enabling precise determination of the sizes of sample molecules. This tool is essential in molecular biology for confirming the identity, purity, and size of biomolecules during experiments.

According to an article published by PLOS One Journal in August 2022, the government of New South Wales in Australia allocated USD 119 million over 10 years to RNA R&D to support a pipeline of research projects.

Market Dynamics:

Driver:

Increased focus on diagnostics and personalized medicine

Personalized medicine requires precise analysis of genetic material and proteins to tailor treatments for individuals, relying heavily on molecular weight markers for size determination of biomolecules. Additionally, advancements in molecular diagnostics, such as the identification of disease biomarkers and development of targeted therapies, necessitate robust tools for protein and DNA analysis. This trend accelerates the adoption of molecular weight markers in genomics, proteomics, and clinical laboratories, fueling market expansion.

Restraint:

Lack of infrastructure and technical expertise

Proper use of molecular weight markers requires specialized tools like electrophoresis systems and expertise in molecular biology techniques. Lack of infrastructure and technical expertise stems from insufficient access to advanced laboratory equipment and skilled personnel. In regions with underdeveloped biotech sectors, limited research funding, and outdated infrastructure, these essential resources are scarce, leading to reduced adoption of molecular weight markers. This restricts research capacity and slows the growth of the market in such regions, limiting its global expansion.

Opportunity:

Advancements in proteomics and genomics research

In proteomics, studying the structure, function, and interactions of proteins requires molecular weight markers for accurate protein sizing and purity assessments during electrophoresis. Similarly, genomics research, which focuses on DNA and RNA sequencing and analysis, relies on these markers to determine nucleic acid sizes in various experiments. The continuous development of new techniques, such as next-generation sequencing and mass spectrometry, further amplifies the need for high-quality molecular weight markers, propelling market expansion in research and biotechnology sectors.

Threat:

High costs of advanced markers

High costs of advanced molecular weight markers arise from the complex manufacturing processes, stringent quality control measures, and the need for specialized materials to ensure accuracy and reliability. Additionally, high costs may deter investment in essential research and development projects, ultimately slowing down innovation in the field. As a result, the financial barrier poses a significant restraint on market growth, preventing many potential users from utilizing these vital tools in their molecular biology applications.

Covid-19 Impact

The covid-19 pandemic significantly impacted the molecular weight marker market, driven by increased demand for research in diagnostics, vaccines, and therapeutic development. Laboratories and biotech firms accelerated molecular biology experiments, such as protein and nucleic acid analysis, to understand the virus and develop treatments. However, supply chain disruptions and restrictions in manufacturing and distribution caused temporary setbacks. Post-pandemic, the market saw steady recovery, with sustained growth due to ongoing research in healthcare, diagnostics, and biotechnology sectors.

The capillary electrophoresis segment is expected to be the largest during the forecast period

The capillary electrophoresis segment is predicted to secure the largest market share throughout the forecast period. Capillary electrophoresis technology in molecular weight marker analysis offers high-resolution separation of biomolecules, such as proteins and nucleic acids, based on size and charge. This method is highly efficient, requiring minimal sample quantities, offering rapid analysis with greater accuracy, and is widely used in genomics, proteomics, and clinical diagnostics.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical companies segment is anticipated to witness the highest CAGR during the forecast period. In pharmaceutical companies, molecular weight markers play a crucial role in drug development and quality control processes. They are used to determine the size and purity of proteins, nucleic acids, and other biomolecules during research and production. Molecular weight markers aid in analyzing the molecular structure of drugs, ensuring consistency and accuracy in formulations.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period driven by rising investments in biotechnology, pharmaceutical research, and academic institutions. Countries like China, India, and Japan are key contributors, with increasing demand for molecular biology tools in genetic research, diagnostics, and drug discovery. Expanding healthcare infrastructure, government initiatives and the presence of numerous biotechnology companies are fueling market expansion in the region.

Region with highest CAGR:

North America is projected to witness the highest CAGR over the forecast period fuelled by advanced research activities in biotechnology and pharmaceuticals. The United States and Canada are key players, benefiting from a strong presence of academic institutions, research centers, and biotech companies. The region's focus on personalized medicine, genomics, and proteomics, along with the rise in demand for diagnostic tools, continues to bolster the demand for molecular weight markers across various applications.

Key players in the market

Some of the key players profiled in the Molecular Weight Marker Market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Sigma-Aldrich, GE Healthcare, Fujifilm Corporation, Becton, Dickinson and Company (BD), PerkinElmer Inc., Agilent Technologies Inc., Roche Diagnostics, VWR International LLC, Abcam plc, Jena Bioscience GmbH, QIAGEN N.V., Amgen Inc., Santa Cruz Biotechnology Inc., Takara Bio Inc., New England Biolabs Inc. (NEB) and Promega Corporation.

Key Developments:

In November 2023, Bio-Rad Laboratories launched a new range of molecular weight markers tailored for high-resolution gel electrophoresis. These markers meet the growing demand for precision in protein analysis, enhancing the accuracy of molecular weight estimation. This innovation supports scientists in achieving more accurate results, reinforcing Bio-Rad's commitment to advancing laboratory technologies.

In August 2023, Thermo Fisher Scientific introduced an upgraded line of prestained molecular weight markers designed to enhance visualization and accuracy in gel electrophoresis, which is crucial for advancements in proteomics research. These markers come in a range of molecular weights, accommodating sizes from as low as 10 kDa to as high as 250 kDa.

In May 2023, Agilent Technologies introduced a new synthetic RNA molecular weight marker designed to enhance RNA analysis workflows. This product specifically targets improvements in techniques like northern blotting, which are essential for studying RNA expression and function in various biological contexts.

Types Covered:

• Protein Markers
• DNA/RNA Markers
• Peptide Markers
• Nucleic Acid Markers
• Other Types

Delivery Methods Covered:

• Liquid Delivery
• Solid Delivery
• Gel-Based Delivery
• Microfluidic Delivery
• Pre-stained Markers
• Other Delivery Methods

Packagings Covered:

• Vials
• Tubes
• Plates
• Sachets
• Cartridges
• Other Packagings

Technologies Covered:

• Capillary Electrophoresis
• Western Blotting
• Mass Spectrometry
• Nuclear Magnetic Resonance (NMR)
• Other Technologies

Applications Covered:

• Research Laboratories
• Biotechnology Companies
• Pharmaceutical Companies
• Clinical Diagnostics
• Academic Institutions
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Molecular Weight Marker Market, By Type

• 5.1 Introduction
• 5.2 Protein Markers
• 5.3 DNA/RNA Markers
• 5.4 Peptide Markers
• 5.5 Nucleic Acid Markers
• 5.6 Other Types

6 Global Molecular Weight Marker Market, By Delivery Method

• 6.1 Introduction
• 6.2 Liquid Delivery
• 6.3 Solid Delivery
• 6.4 Gel-Based Delivery
• 6.5 Microfluidic Delivery
• 6.6 Pre-stained Markers
• 6.7 Other Delivery Methods

7 Global Molecular Weight Marker Market, By Packaging

• 7.1 Introduction
• 7.2 Vials
• 7.3 Tubes
• 7.4 Plates
• 7.5 Sachets
• 7.6 Cartridges
• 7.7 Other Packagings

8 Global Molecular Weight Marker Market, By Technology

• 8.1 Introduction
• 8.2 Capillary Electrophoresis
• 8.3 Western Blotting
• 8.4 Mass Spectrometry
• 8.5 Nuclear Magnetic Resonance (NMR)
• 8.6 Other Technologies

9 Global Molecular Weight Marker Market, By Application

• 9.1 Introduction
• 9.2 Research Laboratories
• 9.3 Biotechnology Companies
• 9.4 Pharmaceutical Companies
• 9.5 Clinical Diagnostics
• 9.6 Academic Institutions
• 9.7 Other Applications

10 Global Molecular Weight Marker Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Bio-Rad Laboratories, Inc.
• 12.2 Thermo Fisher Scientific Inc.
• 12.3 Sigma-Aldrich
• 12.4 GE Healthcare
• 12.5 Fujifilm Corporation
• 12.6 Becton, Dickinson and Company (BD)
• 12.7 PerkinElmer Inc.
• 12.8 Agilent Technologies Inc.
• 12.9 Roche Diagnostics
• 12.10 VWR International LLC
• 12.11 Abcam plc
• 12.12 Jena Bioscience GmbH
• 12.13 QIAGEN N.V.
• 12.14 Amgen Inc.
• 12.15 Santa Cruz Biotechnology Inc.
• 12.16 Takara Bio Inc.
• 12.17 New England Biolabs Inc. (NEB)
• 12.18 Promega Corporation